{
    "clinical_study": {
        "@rank": "293",
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on April 08, 2020",
            "link_text": "Link to the current ClinicalTrials.gov record.",
            "url": "https://clinicaltrials.gov/show/NCT04292340"
        },
        "id_info": {
            "org_study_id": "Anti-SARS-CoV-2",
            "nct_id": "NCT04292340"
        },
        "brief_title": "Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19",
        "official_title": "The Efficacy and Safety of Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of Novel Coronavirus Pneumonia Patient (COVID-19) : An Observational Study",
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai Public Health Clinical Center",
                "agency_class": "Other"
            }
        },
        "source": "Shanghai Public Health Clinical Center",
        "oversight_info": {
            "has_dmc": "No",
            "is_fda_regulated_drug": "No",
            "is_fda_regulated_device": "No"
        },
        "brief_summary": {
            "textblock": "There is still no effective antiviral drugs and vaccines against SARS-CoV-2 yet now. This is\n      an obsevational study, the investigators collected the clinical information and clinical\n      outcomes of the COVID-19 patients using anti-2019-nCoV inactivated convalescent plasma.The\n      study is to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent\n      plasma in the treatment of COVID-19 pneumonia."
        },
        "overall_status": "Recruiting",
        "start_date": {
            "@type": "Actual",
            "#text": "February 1, 2020"
        },
        "completion_date": {
            "@type": "Anticipated",
            "#text": "December 31, 2020"
        },
        "primary_completion_date": {
            "@type": "Anticipated",
            "#text": "July 31, 2020"
        },
        "study_type": "Observational",
        "has_expanded_access": "No",
        "study_design_info": {
            "observational_model": "Case-Only",
            "time_perspective": "Prospective"
        },
        "primary_outcome": [
            {
                "measure": "The virological clearance rate of throat swabs, sputum, or lower respiratory tract secretions at day 1",
                "time_frame": "1 day after receiving plasma transmission",
                "description": "The SARS-CoV-2 nuclei acid was quantified using RT-PCR"
            },
            {
                "measure": "The virological clearance rate of throat swabs, sputum, or lower respiratory tract secretions at day 3",
                "time_frame": "3 days after receiving plasma transmission"
            },
            {
                "measure": "The virological clearance rate of throat swabs, sputum, or lower respiratory tract secretions at day 7",
                "time_frame": "7 days after receiving plasma transmission"
            },
            {
                "measure": "Numbers of participants with different Clinical outcomes",
                "time_frame": "From receiving plasma transmission to 4 weeks",
                "description": "Clinical outcomes include death, critical illness, recovery"
            }
        ],
        "secondary_outcome": {
            "measure": "Number of participants with treatment-related adverse events as assessed by CTCAE v5.0",
            "time_frame": "4 weeks after receiving plasma transmission"
        },
        "enrollment": {
            "@type": "Anticipated",
            "#text": "15"
        },
        "condition": "Coronavirus",
        "eligibility": {
            "study_pop": {
                "textblock": "Participants received anti-SARS-CoV-2 inactivated convalescent plasma"
            },
            "sampling_method": "Non-Probability Sample",
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The participants were diagnosed as COVID-19;\n\n          -  Participants received anti-SARS-CoV-2 inactivated convalescent plasma\n\n          -  Written the informed consent.\n\n        Exclusion Criteria:\n\n          -  Participants lacked detailed medical history"
            },
            "gender": "All",
            "minimum_age": "N/A",
            "maximum_age": "N/A",
            "healthy_volunteers": "No"
        },
        "overall_official": {
            "last_name": "Hongzhou Lu, Ph.D",
            "role": "Principal Investigator",
            "affiliation": "Shanghai Public Health Clinical Center"
        },
        "overall_contact": {
            "last_name": "Hongzhou Lu, Ph.D",
            "phone": "+86-021-37990333",
            "phone_ext": "3222",
            "email": "luhongzhou@fudan.edu.cn"
        },
        "location": {
            "facility": {
                "name": "Shanghai Public Health Clinical Center",
                "address": {
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "zip": "201508",
                    "country": "China"
                }
            },
            "status": "Recruiting",
            "contact": {
                "last_name": "Jun Chen",
                "phone": "008602137990333",
                "phone_ext": "3222"
            }
        },
        "location_countries": {
            "country": "China"
        },
        "verification_date": "February 2020",
        "study_first_submitted": "February 25, 2020",
        "study_first_submitted_qc": "February 28, 2020",
        "study_first_posted": {
            "@type": "Actual",
            "#text": "March 3, 2020"
        },
        "last_update_submitted": "February 28, 2020",
        "last_update_submitted_qc": "February 28, 2020",
        "last_update_posted": {
            "@type": "Actual",
            "#text": "March 3, 2020"
        },
        "responsible_party": {
            "responsible_party_type": "Principal Investigator",
            "investigator_affiliation": "Shanghai Public Health Clinical Center",
            "investigator_full_name": "Hongzhou Lu",
            "investigator_title": "professor"
        },
        "keyword": [
            "Plasma transfusion",
            "Coronavirus"
        ],
        "condition_browse": {
            "mesh_term": "Coronavirus Infections"
        }
    }
}